Neosuberitenone, a New Sesterterpenoid Carbon Skeleton; New Suberitenones; and Bioactivity against Respiratory Syncytial Virus, from the Antarctic Sponge Suberites sp.
Marine Drugs · 2023
DOI: 10.3390/md21020107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2023. Verfasst von Joe Bracegirdle und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of South Florida, 4202 E. Fowler Avenue, CHE205, Tampa, FL 33620, USA. Hauptthemen laut MEDLINE: Suberites, Porifera. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation, NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Respiratory syncytial virus (RSV) is a highly contagious human pathogen that poses a significant threat to children under the age of two, and there is a current need for new small molecule treatments. The Antarctic sponge Suberites sp. is a known source of sesterterpenes, and following an NMR-guided fractionation procedure, it was found to produce several previously unreported metabolites. Neosuberitenone (1), with a new carbon scaffold herein termed the ‘neosuberitane’ backbone, six suberitenone derivatives (2–7), an ansellane-type terpenoid (8), and a highly degraded sesterterpene (9), as well as previously reported suberitenones A (10) and B (11), were characterized. The structures of all of the isolated metabolites including absolute configurations are proposed on the basis of NMR, HRESIMS, optical rotation, and XRD data. The biological activities of the metabolites were evaluated in a range of infectious disease assays. Suberitenones A, B, and F (3) were found to be active against RSV, though, along with other Suberites sp. metabolites, they were inactive in bacterial and fungal screens. None of the metabolites were cytotoxic for J774 macrophages or A549 adenocarcinoma cells. The selectivity of suberitenones A, B, and F for RSV among other infectious agents is noteworthy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of South Florida, 4202 E. Fowler Avenue, CHE205, Tampa, FL 33620, USA.
- Department of Internal Medicine, University of South Florida, Tampa, FL 33612, USA.
- Department of Biology, University of Alabama at Birmingham, 1300 University Blvd, Birmingham, AL 35233, USA.
ORCID-Profile: Joe Bracegirdle, Michael N Teng, Charles D Amsler, Bill J Baker
Förderung
- National Science Foundation
- NIH HHS
- NIAID NIH HHS
- NCCIH NIH HHS
- National Science Foundation Cooperative Agreement
- NIH
Zitieren
APA
Bracegirdle, J., Olsen, S. S. H., Teng, M. N., Tran, K. C., Amsler, C. D., McClintock, J. B., & Baker, B. J. (2023). Neosuberitenone, a New Sesterterpenoid Carbon Skeleton; New Suberitenones; and Bioactivity against Respiratory Syncytial Virus, from the Antarctic Sponge Suberites sp. Marine Drugs. https://doi.org/10.3390/md21020107
Vancouver
Bracegirdle J, Olsen SSH, Teng MN, Tran KC, Amsler CD, McClintock JB, et al. Neosuberitenone, a New Sesterterpenoid Carbon Skeleton; New Suberitenones; and Bioactivity against Respiratory Syncytial Virus, from the Antarctic Sponge Suberites sp. Marine Drugs. 2023. doi:10.3390/md21020107
BibTeX
@article{Bracegirdle2023,
author = {Bracegirdle, Joe and Olsen, Stine S H and Teng, Michael N and Tran, Kim C and Amsler, Charles D and McClintock, James B and Baker, Bill J},
title = {Neosuberitenone, a New Sesterterpenoid Carbon Skeleton; New Suberitenones; and Bioactivity against Respiratory Syncytial Virus, from the Antarctic Sponge Suberites sp},
journal = {Marine Drugs},
year = {2023},
doi = {10.3390/md21020107}
}
EUVIMED